期刊
CURRENT MEDICINAL CHEMISTRY
卷 18, 期 16, 页码 2477-2485出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/092986711795843254
关键词
Dopamine; parkin; phosphorylation; S-nitrosylation; ubiquitylation; neurodegeneration; Parkinson's disease; signaling; substrate; protein interaction; localization
资金
- Spanish Ministry of Science and Innovation (MICINN) [SAF2009-11292, 200920I126]
- Spanish Ministry of Health (FIS) [PI080010]
- Spanish Federation of Parkinson's Disease (FEP)
Parkin functions as an E3 ubiquitin ligase that monoubiquitylates and polyubiquitylates proteins to regulate a variety of cellular processes. It appears that parkin functions as a multipurpose neuroprotectant in a number of toxic paradigms, and loss of parkin's E3 ligase activity seems to play a pathogenic role in both inherited and sporadic Parkinson's disease (PD). Increasing evidence indicates that posttranslational modifications play a major role in regulating parkin's catalytic activity, solubility, substrate selection or subcellular localization. As some of these modification events are subject to pharmacological interventions, these findings may allow for new approaches in preventing or delaying PD onset and/or progression. Here, we review how posttranslational modifications can regulate this unique multifaceted ubiquitin ligase which plays a crucial role for the survival of dopaminergic neurons.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据